Physician Wealth Advisors Inc. Takes Position in Unilever PLC (NYSE:UL)

Physician Wealth Advisors Inc. acquired a new position in Unilever PLC (NYSE:UL) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,627 shares of the company’s stock, valued at approximately $92,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. CIBC Private Wealth Group LLC increased its stake in shares of Unilever by 22.7% during the 4th quarter. CIBC Private Wealth Group LLC now owns 73,077 shares of the company’s stock worth $4,103,000 after purchasing an additional 13,508 shares during the last quarter. Life Planning Partners Inc acquired a new position in Unilever during the fourth quarter worth $1,768,000. Portland Global Advisors LLC raised its holdings in Unilever by 1.1% during the fourth quarter. Portland Global Advisors LLC now owns 107,066 shares of the company’s stock valued at $6,071,000 after buying an additional 1,166 shares in the last quarter. Transamerica Financial Advisors Inc. lifted its position in shares of Unilever by 10.6% in the fourth quarter. Transamerica Financial Advisors Inc. now owns 4,703 shares of the company’s stock worth $267,000 after buying an additional 449 shares during the last quarter. Finally, Intrust Bank NA boosted its stake in shares of Unilever by 13.2% during the 4th quarter. Intrust Bank NA now owns 25,258 shares of the company’s stock worth $1,432,000 after acquiring an additional 2,937 shares in the last quarter. Institutional investors own 9.67% of the company’s stock.

Unilever Price Performance

NYSE:UL opened at $59.18 on Monday. The stock has a market cap of $146.60 billion, a P/E ratio of 16.96, a PEG ratio of 1.60 and a beta of 0.47. The company has a fifty day moving average price of $57.61 and a 200 day moving average price of $59.21. Unilever PLC has a one year low of $46.46 and a one year high of $65.87.

Unilever Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 28th. Investors of record on Friday, February 28th were paid a $0.4674 dividend. This represents a $1.87 annualized dividend and a dividend yield of 3.16%. The ex-dividend date was Friday, February 28th. Unilever’s payout ratio is presently 53.01%.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. DZ Bank upgraded Unilever from a “hold” rating to a “buy” rating in a report on Friday, February 21st. Sanford C. Bernstein raised shares of Unilever from a “hold” rating to a “strong-buy” rating in a report on Thursday, January 9th. Royal Bank of Canada lowered shares of Unilever from a “sector perform” rating to an “underperform” rating in a research note on Monday, January 6th. Finally, StockNews.com raised shares of Unilever from a “hold” rating to a “buy” rating in a research report on Friday, March 7th. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Unilever currently has a consensus rating of “Moderate Buy” and a consensus target price of $66.33.

Unilever Profile

Unilever PLC operates as a fast-moving consumer goods company in the Asia Pacific, Africa, the Americas, and Europe. It operates through five segments: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. The Beauty & Wellbeing segment engages in the sale of hair care products, such as shampoo, conditioner, and styling; skin care products including face, hand, and body moisturizer; and prestige beauty and health & wellbeing products consist of the vitamins, minerals, and supplements.